THOMAS ADAMS
Profile
First Name
: THOMAS
Middle Name
:
Last Name
: ADAMS
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR, EXECUTIVE OFFICER
THOMAS H. ADAMS, THOMAS ADAMS, PH.D., JAMES ARMITAGE, JAMES O. ARMITAGE, PAUL BILLINGS, JOHN BRANCACCIO, JOHN P. BRANCACCIO, GABRIELE CERRONE, ATHENA COUNTOURIOTIS, MARK ERLANDER, MARK ERLANDER, PH.D., GARY JACOB, GARY S. JACOB, GARY JACOB, PH.D., BRIGITTE LINDSAY, RODNEY MARKIN, RODNEY S. MARKIN, GARY W. PACE, GARY PACE, PH.D., DAVID ROBBINS, ANTONIUS SCHUH, STANLEY TENNANT, WILLIAM WELCH, LALE WHITE, STEVE ZANIBOBI, STEVE ZANIBONI
DIRECTOR, EXECUTIVE OFFICER
THOMAS H. ADAMS, THOMAS ADAMS, PH.D., JAMES ARMITAGE, JAMES O. ARMITAGE, PAUL BILLINGS, JOHN BRANCACCIO, JOHN P. BRANCACCIO, GABRIELE CERRONE, ATHENA COUNTOURIOTIS, MARK ERLANDER, MARK ERLANDER, PH.D., GARY JACOB, GARY S. JACOB, GARY JACOB, PH.D., BRIGITTE LINDSAY, RODNEY MARKIN, RODNEY S. MARKIN, GARY W. PACE, GARY PACE, PH.D., DAVID ROBBINS, ANTONIUS SCHUH, STANLEY TENNANT, WILLIAM WELCH, LALE WHITE, STEVE ZANIBOBI, STEVE ZANIBONI
DIRECTOR
SIREESH APPAJOSYULA, TIMOTHY BLOCK, JOHN BRANCACCIO, JOHN P. BRANCACCIO, JOHN CAVAN, BERNARD F. DENOYER, ROBERT FOSTER, TODD HOBBS, BILL HORNUNG, GARY JACOB, GARY S. JACOB, GARY S. JACOBS, KAOUTHAR LBIATI, ARNOLD LIPPA, CHASE LOPRIORE, VINCENT LOPRIORE, CHRISTOPHER MCGUIGAN, MICHAEL PURCELL, ANAND REDDI, JAMES SAPIRSTEIN, GARY STETZ, PETRUS WIJNGAARD
DIRECTOR, EXECUTIVE OFFICER
THOMAS H. ADAMS, THOMAS ADAMS, PH.D., JAMES ARMITAGE, JAMES O. ARMITAGE, PAUL BILLINGS, JOHN BRANCACCIO, JOHN P. BRANCACCIO, GABRIELE CERRONE, ATHENA COUNTOURIOTIS, MARK ERLANDER, MARK ERLANDER, PH.D., GARY JACOB, GARY S. JACOB, GARY JACOB, PH.D., BRIGITTE LINDSAY, RODNEY MARKIN, RODNEY S. MARKIN, GARY W. PACE, GARY PACE, PH.D., DAVID ROBBINS, ANTONIUS SCHUH, STANLEY TENNANT, WILLIAM WELCH, LALE WHITE, STEVE ZANIBOBI, STEVE ZANIBONI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-06-16
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-05-26
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-03-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-08-22
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-05-15
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-04-05
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2019-03-13
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
2017-07-19
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
Equity
2012-11-21
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1 - $1,000,000
Equity
2009-06-10
